Skip to main content
Journal of Community Genetics logoLink to Journal of Community Genetics
. 2013 Jan 15;4(2):233–242. doi: 10.1007/s12687-012-0134-9

A family genetic risk communication framework: guiding tool development in genetics health services

Miriam E Wiens 1,, Brenda J Wilson 2, Christina Honeywell 3, Holly Etchegary 4
PMCID: PMC3666832  PMID: 23319393

Abstract

Family communication of genetic risk information is a complex process. Currently, there are no evidence-based interventions to help genetics professionals facilitate the process of disclosure within families. This study was designed to create a framework to assist in the development of tools to support patients in communicating genetic risk information to family members. A systematic review identified the factors relevant in communicating genetic risk information in families. A guiding theory for the proposed framework was selected and populated with the factors identified from the review. The review identified 112 factors of relevance. The theory of planned behaviour was selected to guide framework development, organising the framework in terms of the patient’s attitudes about disclosure, perceived pressure to disclose and perceived control over disclosure. Attitudes about disclosure are influenced by a desire to protect oneself or family members, and the patient’s perceptions of relevance of the information for family members, responsibility to disclose, family members’ rights to information and the usefulness of communicating. Perceived pressure to disclose information is shaped by genetic professionals, family members and society. Perceived control over disclosure is affected by family relationships/dynamics, personal communication skills, the ability of the patient and family to understand the information and coping skills of the patient and family member. The family genetic risk communication framework presents a concise synthesis of the evidence on family communication of genetic information; it may be useful in creating and evaluating tools to help genetic counsellors and patients with communication issues.

Electronic supplementary material

The online version of this article (doi:10.1007/s12687-012-0134-9) contains supplementary material, which is available to authorized users.

Keywords: Genetic risk, Genetic testing, Family communication, Genetic counselling, Complex interventions, Theory of planned behaviour

Introduction

Genetic testing can provide information about health risks to family members beyond the patient being tested. Passing on information about genetic tests to other family members can provide them with useful information for their own health decision making but may be complicated because not everyone welcomes such information. From the clinical perspective, genetic counsellors sometimes face tensions between their perceptions that other family members should be informed about potential genetic risks, patients’ rights to confidentiality and family members’ rights to receive (or decline) this information (Godard et al. 2006). Research suggests that, in general, most patients do not actively resist passing on genetic information to their relatives when it would be of benefit, but they face multiple issues in working out who needs to know, what to tell them, when, and how (Forrest et al. 2003; Wilson et al. 2004). Several literature reviews have illustrated that family communication is a complex behaviour (Gaff et al. 2007; Wilson et al. 2004; Wilson and Etchegary 2010; Wiseman et al. 2010). However, little attention seems to have been given to developing evidence-based interventions to support professionals in their efforts to facilitate familial communication of genetic risk information (Suthers et al. 2006; van der Roest et al. 2009).

Noting that family communication is a complex issue, we based our approach on the Medical Research Council Complex Interventions Framework (Campbell et al. 2000, 2007). This suggests that trials of complex health care interventions should be preceded by careful development work, preferably informed by an explicit theoretical understanding of both the problem(s) an intervention is designed to address and the rationale for why it might be effective.

Our starting point for this work is that individual patient autonomy must be respected; therefore the general outcome of interest, from a clinical perspective, is that genetic risk information is shared according to a patient’s wishes—this implies an informed decision to disclose risk information. Some patients wish to share risk information but face problems in doing so (Forrest et al. 2003; Chivers Seymour et al. 2010).

The aim of the project reported here was to develop a framework which would organise the factors apparently relevant to family communication at an individual patient level, from the perspective of a health care provider, in order to clarify the nature of issues a patient might face in making a decision about disclosure to relatives and in the process of communication itself. Such a framework would help genetic counsellors promote informed decision making, ‘diagnose’ disclosure or communication problems in their patients and identify the most appropriate interventions to assist them in their communication decisions. The framework would also assist research by highlighting intervention research to meet specific types of communication issues and by focusing attention on specific indicators by which they could be evaluated.

Methods

We conducted the study in two parts: a systematic review to identify the important factors involved in family communication of genetic risk information and synthesis/organisation of this information into a family communication-specific framework.

Systematic review

The purpose of the systematic review was to assemble comprehensive evidence regarding family communication of genetic risk information as a first step to populating a framework. Our starting point was a published systematic review (Wilson et al. 2004) which we expanded and updated to capture all relevant reports from 1900 to 2007. The detailed systematic review methodology, including search strategy, can be found in the Electronic supplementary material (ESM 1). Two people independently screened titles and abstracts for relevance. Studies were retained if: they included participants who had undergone genetic testing for any disorder or were known to be at increased risk for a genetic disorder because of a family history; they aimed to explore, examine or assess any aspect of communication among family members about genetic risk; and used explicitly described qualitative or quantitative methods to address a clearly defined research question. We excluded narratives, commentaries, book chapters and editorials. Because of the wide range of eligible study designs, quantitative synthesis was not considered.

Framework development

Selection of a guiding theory

Anticipating a wide diversity of factors relevant to family communication of genetic risk, we sought an existing general theory or framework as a starting point to organise the results of the systematic review. To do this, we developed five criteria to assist in theory/framework section: (1) relevance to family communication of genetic risk information; (2) ability to incorporate a wide range of factors which might underlie communication of genetic risk information; (3) ability to delineate or categorise target behaviours potentially amenable to intervention (i.e. modifiable factors) and orientation towards clinical and patient decision making/interventions; (4) ability to predict outcome of interest (whether communication would occur); and (5) evidence of validity. We reviewed the published literature and consulted with experts to identify a range of potential theories and reviewed them against these criteria.

Populating the guiding theory

For each study identified in the systematic review, we recorded the reported factors associated (positively or negatively) with family communication. We organised these into a parsimonious list of individual, distinct, mutually exclusive factors (e.g. we conflated ‘not having access to the contact information for a family member’ and ‘not knowing what country they lived in’ into ‘not having information to contact the family member’). We noted the frequency with which the same factor was identified across different studies. Next, we mapped each distinct factor on to the appropriate construct of the pre-selected general theory, categorising the distinct factors into natural sub-themes within each construct as appropriate. Tables which describe the specific process for each factor included in the framework are included in the ESM 2.

As a first check on the completeness of the framework, we conducted a final additional literature search, applying the previous search strategy to identify eligible reports published in Medline to November 2012. We mapped the findings against the framework and sought to identify all issues or observations in this last set of literature that it could not accommodate.

Results

Systematic review

The original review (Wilson et al. 2004) identified 31 relevant reports. The electronic search update resulted in 6,231 citations (1,575 duplicates), with an additional 211 manuscripts identified by independent review of abstracts and titles and retrieved for further examination. After exclusions we included 38 new reports from Nov 2003 to Oct 2007 to give a total of 69 individual studies. A flow diagram documenting inclusion and exclusion can be found in the ESM 1.

The research identified was mostly qualitative or descriptive in nature, consisting of surveys (27), interviews (43), evaluations of clinical tools (2), focus groups (1) and case reports and series (2); we identified no controlled trials. Reports addressed aspects of communication between adults and between adults and children. The reports focused mainly on late-onset, autosomal dominant disorders, particularly hereditary breast and ovarian cancer (35 studies), Huntington’s disease (11 studies) and hereditary colorectal cancer (8 studies). The large group of other conditions comprised cystic fibrosis, sickle cell anemia, Duchenne muscular dystrophy, chromosome translocations/balanced translocations, haemophilia, hereditary melanoma, inherited high cholesterol and hearing loss (Table 1). Detailed information on included studies and a summary of their main findings can be obtained from the corresponding author.

Table 1.

Genetic conditions identified in the systematic review

Disorder Inheritance Citations from systematic review
Late onset
  Hereditary breast and ovarian cancer (BRCA1/2) Autosomal dominant Adelsward and Sachs (2003), Blandy et al. (2003), Bowen et al. (2004), Bradbury et al. (2007), Claes et al. (2003), Clarke et al. (2005), d’Agincourt-Canning (2001), Daly et al. (2003), Farkas Patenaude et al. (2006), Forrest et al. (2003), Forrest Keenan et al. (2005), Foster et al. (2004), Gadzicki et al. (2006), Green et al. (1997), Hallowell et al. (2003, 2005) Hamilton et al. (2005), Hughes et al. (2002), Julian-Reynier et al. (1996, 2000), Kenen et al. (2004a, b), Landsbergen et al. (2005), Lerman et al. (1998), Lim et al. (2004), MacDonald et al. (2007), McGivern et al. (2004), McKinnon et al. (2007), Mellon et al. (2006, 2007), Miesfeldt et al. (2003), Segal et al. (2004), Smith et al. (2002), van Oostrom et al. (2007) and Wagner Costalas et al. (2003)
  Huntington’s disease Autosomal dominant Bruce et al. (2003), Clarke et al. (2005), Cox (1999), Forrest et al. (2003), Forrest Keenan et al. (2005), Hamilton et al. (2005), Holt (2006), Klitzman et al. (2007), Shakespeare (1993), Skirton (1998) and Taylor (2005)
  Hereditary non-polyposis colon cancer (colorectal adenoma) Autosomal dominant Adelsward and Sachs (2003), Berth et al. (2006), Gaff et al. (2005), Koehly et al. (2003), Kohut et al. (2007), Mesters et al. (2005), Peterson et al. (2003) and Schroy et al. (2005)
  Hereditary melanoma Autosomal dominant Kasparian et al. (2006) and Riedijk et al. (2005)
  Inherited high cholesterol (LDLR, APOB, PSCSK9 and LDLRAP1) Autosomal dominant or recessive van den Nieuwenhoff et al. (2006, 2007)
Childhood onset
  Cystic fibrosis Autosomal recessive Denayer et al. (1992a, b), Duster (1999), Fanos and Johnson (1995), Henneman et al. (2002) and Ormond et al. (2003)
  Chromosome translocation/balanced translocations Complex inheritance pattern Ayme et al. (1993), Clarke et al. (2005), Suslak et al. (1985) and Wolff et al. (1989)
  Hemophilia x-linked recessive Gallo et al. (2005), Gregory et al. (2007), Sorenson et al. (2003) and Varekamp et al. (1992)
  Duchenne muscular dystrophy x-linked recessive Fitzpatrick and Barry (1990)
  Sickle cell anemia Autosomal recessive Duster (1999)
  Hearing loss (GJB2 and GJB6) Autosomal dominant Blase et al. (2007)

Framework development

Selection of a guiding theory

We identified nine candidate theories which we rated against five criteria: (1) relevance to family communication of genetic risk information (‘relevance’); (2) ability to incorporate a wide range of factors which underlie communication of genetic risk information (‘range of factors’); (3) ability to delineate or categorise target behaviours amenable to intervention (‘amenable behaviours’); (4) ability to predict whether communication will occur in varying circumstances (‘predictive ability’); and (5) evidence of validity (‘validity’). The theories are summarised in Table 2.

Table 2.

Theories considered for use in developing the family communication of genetic risk framework and ratings against the five key criteria

Theory Relevance Range of factors Amenable behaviours Predictive ability Validity
Circumplex model of marital and family systems (Olson et al. 1989) No Yes No No Yes
Double ABCX model of adjustment and adaptation (McCubbin and Patterson 1983) No Yes No No Yes
The Beaver’s systems model (Beaver and Hampson 2003) No Yes No No Yes
The McMaster model of family functioning (Epstein et al. 2003) No Yes No No Yes
Family communication patterns model (Ritchie and Fitzpatrick 1990) No Yes No No Yes
Health belief model (Rosenstock 1974) No Yes Yes No No
Protection motivation theory (Rogers 1983) No No Yes Yes Yes
Social cognitive theory (Bandura 1986) Yes Yes Yes Yes Yes
Theory of planned behaviour (Ajzen 1991) Yes Yes Yes Yes Yes

Table 2 shows that two theories met all criteria, the social cognitive theory (Bandura 1986) and the theory of planned behaviour (TPB) (Ajzen 1991). We selected the latter for the purposes of our study because it has a greater amount of empirical evidence supporting its validity, it is the most widely used model of the psychosocial determinants of behaviour, and because it has been used across a wide variety of healthcare settings and behaviours (Armitage and Conner 2001; Godin and Kok 1996; Hardeman et al. 2002). Empirical analyses suggest that, on average, its constructs predict about 40 % of the variance in intention and about 20–30 % of the variance in behaviour (Armitage and Conner 2001; Godin and Kok 1996; Hardeman et al. 2002; Sheeran 2002). The TPB has also been used extensively in the health professional and patient setting examining decision making and behaviour (Allaire et al. 2012; Kasper et al. 2012; Simms et al. 2012; Trinh et al. 2012).

The TPB suggests that behaviour (e.g. disclosing risk information to a target relative) is predicted by the strength of an individual’s intention to perform it (see Fig. 1). Intention, in turn, is determined by three constructs, i.e. an individual’s attitude towards the behaviour (box d), perceived social pressure to perform the behaviour (box e) and perceived behavioural control over the behaviour (box f) (Ajzen 1991). Attitudes are formed from beliefs about the outcomes of the behaviour (behavioural beliefs), weighted by positive or negative evaluations of that outcome (box a). Depending on whether the behavioural beliefs are positively or negatively evaluated, the result will be a favorable or unfavorable attitude toward the behaviour. Subjective norm (SN) is a function of an individual’s beliefs about the expectations of other important individuals or groups (normative beliefs) and the person’s motivation to comply with these groups (motivation to comply; box b). Perceived behavioural control (PBC) is predicted by beliefs about factors likely to facilitate or inhibit the behaviour (control beliefs) and an evaluation of the power that each factor has to affect behaviour (power; box c). Demographic and personality factors are assumed to affect behaviour indirectly through their influence on attitude, norms and control beliefs (Ajzen 1991, 2007).

Fig. 1.

Fig. 1

Theory of planned behaviour (Ajzen 1991)

Populating the guiding theory

A total of 112 discrete factors relating to family communication of genetic risk information were identified through the systematic review. Table 3 summarises those most frequently cited, describes the subsequent theme each factor represents in the framework and the construct of the TPB within which the factor and theme fall. The factors formed 12 themes, 5 within the attitude construct, three within the SN construct and 4 within the PBC construct.

Table 3.

The most frequently cited factors perceived as affecting communication of genetic risk information among family members according to the number of times cited in the literature

Communication factor TPB construct Theoretical framework theme No. of citations
Desire to protect oneself and family from potentially harmful information Attitude Desire to protect 21
Age and maturity level of recipient Attitude Desire to protect and perception of relevance 15
Existence of unhealthy family relationships PBC Family dynamics and relationships 14
Lack of contact with the recipient PBC Family dynamics and relationships 13
Feelings of responsibility to inform the recipient Attitude Perception of responsibility 13
Lack of emotional closeness between the recipient and teller PBC Family dynamics and relationships 10
Perception that the information is not relevant to the recipient Attitude Perception of relevance 8
Belief that the recipient has a right to the information Attitude Perceptions of ‘right to know’ 7
Feelings of guilt Attitude Desire to protect 7
Viewing communication as a means to social support Attitude Desire to protect 7
Situational factors of the recipient (e.g. drug abuse, illness, pregnancy and marriage plans) Attitude Desire to protect 7

Female sex was the most commonly cited factor (22 citations); however, according to TPB theory, demographic factors of the communicator fall within the external factors influencing the TBP constructs

Figure 2 depicts the final family genetic risk communication framework, populated by the findings of the systematic review. It organises the 112 factors into their relevant domains and highlights the way in which they might interact in promoting or preventing ‘intention to communicate genetic risk information’.

Fig. 2.

Fig. 2

TPB-based family genetic risk communication framework

The factors within each TPB construct should act in a positive or negative way to form an individual’s attitude, PBC and SN, which in turn, should predict their intention to communicate. Factors influential in forming any three of the constructs (their attitude, PBC and SN) with regard to disclosure may be in conflict, may all be positive or may all be negative. Some, all, or none of those particular factors might apply in the formation of each construct for any given individual. In keeping with the TPB, ‘intention’ is construed as the function of all three constructs (Ajzen 1988, 2007). The weight each construct carries for each individual may be different because attitudes, PBC and SN and the factors which influence their formation, will vary between people and situations. Despite these differences, however, the theory defines communication behaviour as a function of these three main constructs. It provides a parsimonious account of a complex behaviour.

In the case of disclosure of genetic test results to at-risk family members, the framework predicts that an individual’s attitude towards disclosure of genetic risk information to a relative is potentially formed by one or more of the following factors: a desire to protect the relative in question and/or oneself from harmful news, perception of the relevance of the genetic risk information for the relative, perception of disclosure responsibilities, assessment of the relative’s right to the genetic information and perception of how useful the information will be to that relative.

Four themes emerged which affect perceptions of behavioural control: the family dynamics and relationships within the family, the individual’s communication skills, whether the individual and family member has the ability to understand complex genetic information and whether the individual and family member has skills to cope with his or her own bad news as well as the reactions of others.

In terms of the pressure that an individual feels to perform (or not perform) the behaviour (i.e. communicate or not), the literature identified three sources of pressure: other family members, for example, a relative who wants to control family information or a receiver of information who does not want to know, genetic professionals or other health professionals and society as a whole in the form of the ‘appropriateness’ of discussing such topics.

Overall, the strength of an individual’s attitudes, perception of control over the behaviour and the pressure to tell or not tell will determine one’s intention to disclose genetic risk information. The systematic review identified immutable factors such as culture, past experience, personality, disease severity and gender that are also thought to influence communication of genetic risk. In the model, their effect on communication intention and behaviour are assumed to be mediated through attitude, SN and PBC.

In our check of the framework, our search of MedLine identified 53 additional articles published between 2007 and 2012 which met the original eligibility criteria. All communication-related factors reported could be accommodated in the framework without revision or adaptation.

Discussion

There is a wealth of information available on the topic of family communication of genetic risk information. The wide and varied literature, however, makes it difficult to translate research findings to the development of interventions for patients and their families. Published models created to explain the process of disclosure were developed with the intention to explain a very complex process (Barsevick et al. 2008). For example, the application of the social-ecological model to communication in families with inherited hyperlipidaemia (van den Nieuwenhoff et al. 2007) or Klitzman et al.’s (2007) analysis of the factors considered in relation to Huntington disease risk disclosure. In both cases, the model development was secondary to the exploration of the issue and not the original purpose of these studies. It is reassuring to note that the content of both models is consistent with our proposed framework, suggesting that regardless of the lens used to examine the issue, similar barriers and facilitators are identified. Family-centric models have also been developed which examine the issues faced by individuals and families arising during genetic testing in general (Rolland and Williams 2005; Peterson 2005). These more general models have highlighted family communication as an important factor and are both consistent with and complement the family genetic risk communication framework.

The value of an organising framework lies in its insights from diverse disciplines and disorders and in offering a parsimonious explanation of family communication factors to act as a bridge to alterations in clinical practice. We suggest that family genetic risk communication framework may facilitate the diagnosis of problems faced by patients, support informed decision making on whether and how to disclose information and the conceptualisation and development of interventions explicitly targeting particular genetic risk communication barriers. However, at this stage of its development, we do not propose that it is a fully validated guide for genetic risk communication intervention development. Nevertheless, given that the framework is derived from an existing theory which itself has been validated, the component constructs may be more amenable to change by carefully targeted interventions than those which come from a ‘black box’ approach (Campbell et al. 2000, 2007; Michie 2008). As a minimum, we hope it will stimulate discussion, and it may find use in its current form as an educational tool for genetic counselors or as an aide memoire in the clinic.

Supporting patients in working through their disclosure or communication issues is unlikely to be a simple task in clinical practice. Tools designed to support clinicians will probably fall under the concept of ‘complex intervention’ (Campbell et al. 2000, 2007), that is, their effectiveness will be affected by multiple factors such as the setting in which they are used, the skills and experience of the practitioner using them, the level of training available, the time available to implement them in practice, how rigidly they have to be applied and other contextual variables. Emery (2005) is an example in genetics of how recognising intervention complexity is useful in tool development. Over a series of studies, Emery et al. illustrated the development of the GRAIDS decision support tool for genetics referral decisions by family physicians, from exploratory research (Emery et al. 1999b), to a simple prototype tool (Emery et al. 1999a, 2000) through to a computerised system supported by specific education and training (Emery et al. 2007). The study reported here is the first step in applying a similar process to developing clinical practice tools to support decisions and actions around family communication of genetic risk. It promotes clarity about the different kinds of underlying disclosure or communication challenges and indicates the socio-cognitive constructs that may be the most amenable targets for specific intervention development.

The study reported here has limitations. Firstly, the systematic review, while comprehensive, was qualitative in nature. Therefore, while the themes identified are probably a realistic representation of the issues, we cannot claim that they represent the frequency of issues encountered by typical populations of patients attending genetics clinics. In addition, there are many other base frameworks which could have been selected as a starting point. Within the genetics literature, for example, the three themes identified by Dancyger et al. (2011) might be a useful starting point: responsibility to tell, perceived emotional and developmental readiness of the information recipient and communication within the existing family culture. Looking outside genetics, the emergence of the theoretical domains framework (Francis et al. 2012; Cane et al. 2012) also offers a more comprehensive approach which draws together the overlapping constructs represented in multiple individual behavioural theories. The framework is generic, and its applicability to the special issues of communication with (non-adult) children may be under-developed. This is an area of special sensitivity with many ethical concerns, and a detailed exploration of this matter was not within the scope of the current research.

The application of the framework presents the possibility of patient- and situation-specific interventions, focused on particular constructs such as attitude to communicating risk information or perceptions of control over communication. Ultimately, we envisage a toolbox of interventions from which the genetics professional may match the appropriate interventions for each client. Finally, the framework could accommodate intervention design for family members other than the index patient.

Electronic supplementary material

ESM 1 (195.9KB, pdf)

(PDF 195 kb)

ESM 2 (509.7KB, pdf)

(PDF 509 kb)

Acknowledgments

Conflict of interest statement

The authors declare that they have no conflict of interest.

References

  1. Adelsward V, Sachs L. The messenger's dilemmas - giving and getting information in genealogical mapping for hereditary cancer. Health Risk Soc. 2003;5(2):125–138. doi: 10.1080/1369857031000123911. [DOI] [Google Scholar]
  2. Ajzen I. Attitudes, personality and behavior. Buckingham: Open University Press; 1988. [Google Scholar]
  3. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179–211. doi: 10.1016/0749-5978(91)90020-T. [DOI] [Google Scholar]
  4. Ajzen I (2007) The theory of planned behavior. Available from http://people.umass.edu/aizen/tpb.html. Accessed 09 Dec 2007
  5. Allaire AS, Labrecque M, Giguere A, Gagnon MP, Légaré F. What motivates family physicians to participate in training programs in shared decision making? J Contin Educ Health Prof. 2012;32(2):98–107. doi: 10.1002/chp.21132. [DOI] [PubMed] [Google Scholar]
  6. Armitage CJ, Conner M. Efficacy of the theory of planned behavior: a meta-analytic review. Br J Soc Psychol. 2001;40(Pt 4):471–499. doi: 10.1348/014466601164939. [DOI] [PubMed] [Google Scholar]
  7. Ayme S, quart-Moulin G, Julian-Reynier C, Chalbal F, Giraud F. Diffusion of information about genetic risk within families. Neuromuscul Disord. 1993;3(5–6):571–574. doi: 10.1016/0960-8966(93)90118-4. [DOI] [PubMed] [Google Scholar]
  8. Bandura A. Social foundations of thought and action. Englewood Cliffs: Prentice-Hall; 1986. [Google Scholar]
  9. Barsevick AM, Montgomery SV, Ruth K, Ross EA, Egleston BL, Bingler R, Malick J, Miller SM, Cescon TP, Daly MB. Intention to communicate BRCA1/BRCA2 genetic test results to the family. J Fam Psychol. 2008;22(2):303–312. doi: 10.1037/0893-3200.22.2.303. [DOI] [PubMed] [Google Scholar]
  10. Beaver SB, Hampson RB. Measuring family competence: The Beavers systems model. In: Walsh F, editor. Normal family processes: growing diversity and complexity. 3. New York: Guilford Press; 2003. pp. 549–580. [Google Scholar]
  11. Berth H, Dinkel A, Kruger S, Bier A, Blck F. Factors that influence family communication about genetic counselling for hereditary colorectal cancer—abstracts of the 8th World Congress of Psycho-oncology. Psychooncology. 2006;15(2 Suppl):S175. [Google Scholar]
  12. Blandy C, Chabal F, Stoppa-Lyonnet D, Julian-Reynier C. Testing participation in BRCA1/2 positive families: initiator role of index cases. Genet Test. 2003;7(3):225–233. doi: 10.1089/109065703322537241. [DOI] [PubMed] [Google Scholar]
  13. Blase T, Martinez A, Grody WW, Schimmenti L, Palmer CG. Sharing GJB2/GJB6 genetic test information with family members. J Genet Counsel. 2007;16(3):313–324. doi: 10.1007/s10897-006-9066-z. [DOI] [PubMed] [Google Scholar]
  14. Bowen DJ, Bourcier E, Press N, Lewis FM, Burke W. Effects of individual and family functioning on interest in genetic testing. Community Genet. 2004;7(1):25–32. doi: 10.1159/000080301. [DOI] [PubMed] [Google Scholar]
  15. Bradbury AR, Dignam JJ, Ibe CN, Auh SL, Hlubocky FJ, Cummings SA, White M, Olopade OT, Daugherty CK. How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults. J Clin Oncol. 2007;25(24):3705–3711. doi: 10.1200/JCO.2006.09.1900. [DOI] [PubMed] [Google Scholar]
  16. Bruce AM, Semper J, Simpson SA (2003) The impact of presymptomatic predictive testing for Huntington’s disease on partners and marital relationships: secrets, lies and truths. In: Proceedings of the World Congress on Huntington’s Disease, Toronto, Ontario, 20 August
  17. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000;321(7262):694–696. doi: 10.1136/bmj.321.7262.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, Guthrie B, Lester H, Wilson P, Kinmonth AL. Designing and evaluating complex interventions to improve health care. BMJ. 2007;334(7591):455–459. doi: 10.1136/bmj.39108.379965.BE. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Cane J, O’Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci. 2012;7:37. doi: 10.1186/1748-5908-7-37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Chivers Seymour K, Addington-Hall J, Lucassen AM, Foster CL. What facilitates or impedes family communication following genetic testing for cancer risk? A systematic review and meta-synthesis of primary qualitative research. J Genet Couns. 2010;19(4):330–342. doi: 10.1007/s10897-010-9296-y. [DOI] [PubMed] [Google Scholar]
  21. Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Legius E. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet A. 2003;116A(1):11–19. doi: 10.1002/ajmg.a.10868. [DOI] [PubMed] [Google Scholar]
  22. Clarke A, Richards M, Kerzin-Storrar L, Halliday J, Young MA, Simpson SA, Featherstone K, Forrest K, Lucassen A, Morrison PJ, Quarrell OWJ, Stewart H. Genetic professionals' reports of nondisclosure of genetic risk information within families. Eur J Human Genet. 2005;13(5):556–562. doi: 10.1038/sj.ejhg.5201394. [DOI] [PubMed] [Google Scholar]
  23. Cox SM (1999) ‘It’s not a secret but…’: predictive testing and patterns of communication about genetic information in families at risk for Huntington Disease. Dissertation, University of British Columbia
  24. d’Agincourt-Canning L. Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics. 2001;15(3):231–247. doi: 10.1111/1467-8519.00234. [DOI] [PubMed] [Google Scholar]
  25. Daly PA, Nolan C, Green A, Ormiston W, Cody N, McDevitt T, O’hIci B, Byrne D, McDermott E, Carney DN, O’Higgins N, Barton DE. Predictive testing for BRCA1 and 2 mutations: a male contribution. Ann Oncol. 2003;14(4):549–553. doi: 10.1093/annonc/mdg164. [DOI] [PubMed] [Google Scholar]
  26. Dancyger C, Wiseman M, Jacobs C, Smith JA, Wallace M, Michie S. Communicating BRCA 1/2 genetic test results within the family: a qualitative analysis. Psychol Health. 2011;26(8):1018–1035. doi: 10.1080/08870446.2010.525640. [DOI] [PubMed] [Google Scholar]
  27. Denayer L, De Boeck K, Evers-Kiebooms G, Van den Berghe H. The transfer of information about genetic transmission to brothers and sisters of parents with a CF-child. Birth Defects Orig Artic Ser. 1992;28(1):149–158. [PubMed] [Google Scholar]
  28. Denayer L, Evers-Kiebooms D, De Boeck K, Van den Berghe H. Reproductive decision making of aunts and uncles of a child with cystic fibrosis: genetic risk perception and attitudes toward carrier identification and prenatal diagnosis. Am J Med Genet. 1992;44(1):104–111. doi: 10.1002/ajmg.1320440124. [DOI] [PubMed] [Google Scholar]
  29. Duster T. The social consequences of genetic disclosure. In: Carson R, Rothstein M, editors. Behavioral genetics: the clash of culture and biology. Baltimore: Johns Hopkins University Press; 1999. pp. 172–188. [Google Scholar]
  30. Emery J. The GRAIDS Trial: the development and evaluation of computer decision support for cancer genetic risk assessment in primary care. Ann Hum Biol. 2005;32(2):218–227. doi: 10.1080/03014460500074921. [DOI] [PubMed] [Google Scholar]
  31. Emery J, Walton R, Coulson A, Glasspool D, Ziebland S, Fox J. Computer support for recording and interpreting family histories of breast and ovarian cancer in primary care (RAGs): qualitative evaluation with simulated patients. BMJ. 1999;319(7201):32–36. doi: 10.1136/bmj.319.7201.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Emery J, Watson E, Rose P, Andermann A. A systematic review of the literature exploring the role of primary care in genetic services. Fam Pract. 1999;16(4):426–445. doi: 10.1093/fampra/16.4.426. [DOI] [PubMed] [Google Scholar]
  33. Emery J, Walton R, Murphy M, Austoker J, Yudkin P, Chapman C, Coulson A, Glasspool D, Fox J. Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases. BMJ. 2000;321(7252):28–32. doi: 10.1136/bmj.321.7252.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Emery J, Morris H, Goodchild R, Fanshaw T, Prevost AT, Bobrow M, Kinmonth AL. The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer. 2007;97(4):486–493. doi: 10.1038/sj.bjc.6603897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Epstein NB, Bishop DS, Ryan C, Miller I, Keitner G. The McMaster model: a view of healthy family functioning. In: Walsh F, editor. Normal family processes: Growing diversity and complexity. 3. New York: Guildford Press; 2003. pp. 581–607. [Google Scholar]
  36. Fanos JH, Johnson JP. Barriers to carrier testing for adult cystic fibrosis sibs: the importance of no knowing. Am J Med Genet. 1995;59(1):85–91. doi: 10.1002/ajmg.1320590117. [DOI] [PubMed] [Google Scholar]
  37. Farkas Patenaude A, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol. 2006;24(4):700–706. doi: 10.1200/JCO.2005.01.7541. [DOI] [PubMed] [Google Scholar]
  38. Fitzpatrick C, Barry C. Cultural differences in family communication about Duchenne muscular dystrophy. Dev Med Child Neurol. 1990;32(11):967–973. doi: 10.1111/j.1469-8749.1990.tb08119.x. [DOI] [PubMed] [Google Scholar]
  39. Forrest Keenan K, Simpson SA, Wilson BJ, van Teijlingen ER, McKee L, Haites N, Matthews E. 'It's their blood not mine': who's responsible for (not) telling relatives about genetic risk? Health Risk Soc. 2005;7(3):209–226. doi: 10.1080/13698570500229606. [DOI] [Google Scholar]
  40. Forrest K, Simpson SA, Wilson BJ, van Teijlingen ER, McKee L, Haites N, Matthews E. To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet. 2003;64(4):317–326. doi: 10.1034/j.1399-0004.2003.00142.x. [DOI] [PubMed] [Google Scholar]
  41. Foster C, Eeles R, Ardern-Jones A, Moynihan C, Watson M. Juggling roles and expectations: dilemmas faced by women talking to relatives about cancer and genetic testing. Psychol Health. 2004;19(4):439–455. doi: 10.1080/08870440410001684168. [DOI] [Google Scholar]
  42. Francis JJ, O’Connor D, Curran J. Theories of behaviour change synthesised into a set of theoretical groupings: introducing a thematic series on the theoretical domains framework. Implement Sci. 2012;7:35. doi: 10.1186/1748-5908-7-35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Gadzicki D, Wingen LU, Teige B, Horn D, Bosse K, Kreuz F, Goecke T, Schäfer D, Voigtländer T, Fischer B, Froster U, Welling B, Debatin I, Weber BH, Schönbuchner I, Nippert I, Schlegelberger B, German Cancer Aid Consortium on Hereditary Breast and Ovarian Cancer Communicating BRCA1 and BRCA2 genetic test results. J Clin Oncol. 2006;24(18):2969–2970. doi: 10.1200/JCO.2006.06.3750. [DOI] [PubMed] [Google Scholar]
  44. Gaff CL, Collins V, Symes T, Halliday J. Facilitating family communication about predictive genetic testing: probands' perceptions. J Genet Couns. 2005;14(2):133–140. doi: 10.1007/s10897-005-0412-3. [DOI] [PubMed] [Google Scholar]
  45. Gaff CL, Clarke AJ, Atkinson P, Sivell S, Elwyn G, Iredale R, Thornton H, Dundon J, Shaw C, Edwards A. Process and outcome in communication of genetic information within families: a systematic review. Eur J Hum Genet. 2007;15(10):999–1011. doi: 10.1038/sj.ejhg.5201883. [DOI] [PubMed] [Google Scholar]
  46. Gallo AM, Angst D, Knafl KA, Hadley E, Smith C. Parents sharing information with their children about genetic conditions. J Pediatr Health Care. 2005;19(5):267–275. doi: 10.1016/j.pedhc.2005.05.008. [DOI] [PubMed] [Google Scholar]
  47. Godard B, Hurlimann T, Letendre M, Egalité N, INHERIT BRCAs Guidelines for disclosing genetic information to family members: from development to use. Fam Cancer. 2006;5:103–116. doi: 10.1007/s10689-005-2581-5. [DOI] [PubMed] [Google Scholar]
  48. Godin G, Kok G. The theory of planned behavior: a review of its applications to health-related behaviors. Am J Health Promot. 1996;11(2):87–98. doi: 10.4278/0890-1171-11.2.87. [DOI] [PubMed] [Google Scholar]
  49. Green J, Richards M, Murton F, Statham H, Hallowell N. Family communication and genetic counseling: the case of hereditary breast and ovarian cancer. J Genet Couns. 1997;6(1):45–60. doi: 10.1023/A:1025611818643. [DOI] [PubMed] [Google Scholar]
  50. Gregory M, Boddington P, Dimond R, Atkinson P, Clarke A, Collins P. Communicating about haemophilia within the family: the importance of context and of experience. Haemophilia. 2007;13(2):189–198. doi: 10.1111/j.1365-2516.2006.01417.x. [DOI] [PubMed] [Google Scholar]
  51. Hallowell N, Foster C, Eeles R, Ardern-Jones A, Murday V, Watson M. Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information. J Med Ethics. 2003;29(2):74–79. doi: 10.1136/jme.29.2.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Hallowell N, Ardern-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C, Watson M. Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems. Clin Genet. 2005;67(6):492–502. doi: 10.1111/j.1399-0004.2005.00443.x. [DOI] [PubMed] [Google Scholar]
  53. Hamilton RJ, Bowers BJ, Williams JK. Disclosing genetic test results to family members. J Nurs Scholarsh. 2005;37(1):18–24. doi: 10.1111/j.1547-5069.2005.00007.x. [DOI] [PubMed] [Google Scholar]
  54. Hardeman W, Johnston M, Johnston D, Bonetti D, Wareham N, Kinmonth A. Application of the theory of planned behaviour in behaviour change interventions: a systematic review. Psychol Health. 2002;17(2):123–158. doi: 10.1080/08870440290013644a. [DOI] [Google Scholar]
  55. Henneman L, Kooij L, Bouman K, ten Kate LP. Personal experiences of cystic fibrosis (CF) carrier couples prospectively identified in CF families. Am J Med Genet. 2002;110(4):324–331. doi: 10.1002/ajmg.10464. [DOI] [PubMed] [Google Scholar]
  56. Holt K. What do we tell the children? Contrasting the disclosure choices of two HD families regarding risk status and predictive genetic testing. J Genet Couns. 2006;15(4):253–265. doi: 10.1007/s10897-006-9021-z. [DOI] [PubMed] [Google Scholar]
  57. Hughes C, Lerman C, Schwartz M, Peshkin BN, Wenzel L, Narod S, Corio C, Tercyak KP, Hanna D, Isaacs C, Main D. All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet. 2002;107(2):143–150. doi: 10.1002/ajmg.10110. [DOI] [PubMed] [Google Scholar]
  58. Julian-Reynier C, Eisinger F, Vennin P, Chabal F, Aurran Y, Noguès C, Bignon Y-J, Machelard-Roumagnac M, Maugard-Louboutin C, Serin D, Blanc B, Orsoni P, Sobol H. Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet. 1996;33(9):731–736. doi: 10.1136/jmg.33.9.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Julian-Reynier C, Eisinger F, Chabal F, Lasset C, Noguès C, Stoppa-Lyonnet D, Vennin P, Sobol H. Disclosure to the family of breast/ovarian cancer genetic test results: patient's willingness and associated factors. Am J Med Genet. 2000;94(1):13–18. doi: 10.1002/1096-8628(20000904)94:1<13::AID-AJMG4>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  60. Kasparian NA, Meiser B, Butow PN, Job RF, Mann GJ. High-risk individuals’ anticipated psychological responses to genetic testing for melanoma susceptibility. J Genet Couns. 2006;15(6):433–447. doi: 10.1007/s10897-006-9038-3. [DOI] [PubMed] [Google Scholar]
  61. Kasper J, Köpke S, Fischer K, Schäffler N, Backhus I, Solari A, Heesen C. Applying the theory of planned behaviour to multiple sclerosis patients' decisions on disease modifying therapy—questionnaire concept and validation. BMC Med Inform Decis Mak. 2012;12(2):60. doi: 10.1186/1472-6947-12-60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Kenen R, Arden-Jones A, Eeles R. We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian cancer (HBOC) Psychooncology. 2004;13(5):335–345. doi: 10.1002/pon.745. [DOI] [PubMed] [Google Scholar]
  63. Kenen R, Arden-Jones A, Eeles R. Healthy women from suspected hereditary breast and ovarian cancer families: the significant others in their lives. Eur J Cancer Care (Engl) 2004;13(2):169–179. doi: 10.1111/j.1365-2354.2004.00460.x. [DOI] [PubMed] [Google Scholar]
  64. Klitzman R, Thorne D, Williamson T, Chung W, Marder K. Disclosure of Huntington’s disease risk within families: patterns of decision-making and implications. Am J Med Genet A. 2007;143A:1835–1849. doi: 10.1002/ajmg.a.31864. [DOI] [PubMed] [Google Scholar]
  65. Koehly LM, Peterson SK, Watts BG, Kempf KK, Vernon SW, Gritz ER. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiol Biomarkers Prev. 2003;12(4):304–313. [PubMed] [Google Scholar]
  66. Kohut K, Manno M, Gallinger S, Esplen MJ. Should healthcare providers have a duty to warn family members of individuals with an HNPCC-causing mutation? A survey of patients from the Ontario Familial Colon Cancer Registry. J Med Genet. 2007;44(6):404–407. doi: 10.1136/jmg.2006.047357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Landsbergen K, Verhaak C, Kraaimaat F, Hoogerbrugge N. Genetic uptake in BRCA—mutation families is related to emotional and behavioral communication characteristics of index patients. Fam Cancer. 2005;4(2):115–119. doi: 10.1007/s10689-004-7991-2. [DOI] [PubMed] [Google Scholar]
  68. Lerman C, Peshkin BN, Hughes C, Isaacs C. Family disclosure in genetic testing for cancer susceptibility: determinants and consequences. J Health Care Law Policy. 1998;1(2):353–373. [Google Scholar]
  69. Lim J, Macluran M, Price M, Bennett B, Butow P, kConFab Psychosocial Group Short- and long-term impact of receiving genetic mutation results in women at increased risk for hereditary breast cancer. J Genet Couns. 2004;13(2):115–133. doi: 10.1023/B:JOGC.0000018822.56297.a6. [DOI] [PubMed] [Google Scholar]
  70. MacDonald DJ, Sarna L, van Servellen G, Bastani R, Giger JN, Weitzel JN. Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment. Genet Med. 2007;9(5):275–282. doi: 10.1097/GIM.0b013e31804ec075. [DOI] [PubMed] [Google Scholar]
  71. McCubbin HI, Patterson JM. The family stress process: the double ABCX model of adjustment and adaptation. In: McCubbin HI, Sussman MB, Patterson JM, editors. Social stress and the family: advances and developments in family stress theory and research. New York: Haworth Press Inc; 1983. pp. 7–37. [Google Scholar]
  72. McGivern B, Everett J, Yager GG, Baumiller RC, Hafertepen A, Saal HM. Family communication about positive BRCA1 and BRCA2 genetic test results. Genet Med. 2004;6(6):503–509. doi: 10.1097/01.GIM.0000144014.91237.A1. [DOI] [PubMed] [Google Scholar]
  73. McKinnon W, Naud S, Ashikaga T, Colletti R, Wood M. Results of an intervention for individuals and families with BRCA mutations: a model for providing medical updates and psychosocial support following genetic testing. J Genet Couns. 2007;16(4):433–456. doi: 10.1007/s10897-006-9078-8. [DOI] [PubMed] [Google Scholar]
  74. Mellon S, Berry-Bobovski L, Gold R, Levin N, Tainsky MA. Communication and decision-making about seeking inherited cancer risk information: findings from female survivor-relative focus groups. Psychooncology. 2006;15(3):193–208. doi: 10.1002/pon.935. [DOI] [PubMed] [Google Scholar]
  75. Mellon S, Berry-Bobovski L, Gold R, Janisse J, Tainsky M. Communicating about cancer risk in high-risk families: a comparison between breast and ovarian cancer survivors and their female relatives. Oncol Nurs Forum. 2007;34(1):227. [Google Scholar]
  76. Mesters I, Ausems M, Eichhorn S, Vasen H. Informing one's family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study. Fam Cancer. 2005;4(2):163–167. doi: 10.1007/s10689-004-7992-1. [DOI] [PubMed] [Google Scholar]
  77. Michie S. Designing and implementing behavior change interventions to improve population health. J Health Serv Res Pol. 2008;13(Supp 3):64–69. doi: 10.1258/jhsrp.2008.008014. [DOI] [PubMed] [Google Scholar]
  78. Miesfeldt S, Cohn WF, Jones SM, Ropka ME, Weinstein JC. Breast cancer survivors' attitudes about communication of breast cancer risk to their children. Am J Med Genet C Semin Med Genet. 2003;119C(1):45–50. doi: 10.1002/ajmg.c.10012. [DOI] [PubMed] [Google Scholar]
  79. Olson DH, Russel CS, Sprenkle DH. Circumplex model: systemic assessment and treatment of families. New York: Haworth Press Inc; 1989. [Google Scholar]
  80. Ormond KE, Mills PL, Lester LA, Ross LF. Effect of family history on disclosure patterns of cystic fibrosis carrier status. Am J Med Genet C Semin Med Genet. 2003;119C(1):70–77. doi: 10.1002/ajmg.c.10008. [DOI] [PubMed] [Google Scholar]
  81. Peterson SK (2005) The role of the family in genetic testing: theoretical perspectives, current knowledge, and future directions. Health Educ Behav 32(5):627–639 [DOI] [PubMed]
  82. Peterson SK, Watts BG, Koehly LM, Vernon SW, Baile WF, Kohlmann WK, Gritz ER. How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet C Semin Med Genet. 2003;119C(1):78–86. doi: 10.1002/ajmg.c.10010. [DOI] [PubMed] [Google Scholar]
  83. Riedijk SR, de Snoo FA, van Dijk S, Bergman W, van Haeringen A, Silberg S, van Elderen TM, Tibben A. Hereditary melanoma and predictive genetic testing: why not? Psychooncology. 2005;14(9):738–745. doi: 10.1002/pon.901. [DOI] [PubMed] [Google Scholar]
  84. Ritchie DL, Fitzpatrick M. Family communication patterns: measuring intrapersonal perceptions and interpersonal relationships. Communic Res. 1990;17(4):523–544. doi: 10.1177/009365090017004007. [DOI] [Google Scholar]
  85. Rogers RW. Cognitive and physiological processes in fear appeals and attitude change: a revised theory of protection motivation. In: Cacioppo JT, Petty RE, editors. Social psychophysiology: a sourcebook. New York: Guildford Press; 1983. pp. 153–176. [Google Scholar]
  86. Rolland JS, Williams JK. Toward a biopsychosocial model for 21st-century genetics. Fam Process. 2005;44(1):3–24. doi: 10.1111/j.1545-5300.2005.00039.x. [DOI] [PubMed] [Google Scholar]
  87. Rosenstock I. Historical origins of the health belief model. In: Green L, editor. Health education monographs. San Francisco: Society for Public Health Education; 1974. pp. 354–386. [Google Scholar]
  88. Schroy PC, 3rd, Lal SK, Wilson S, Heeren T, Farraye FA. Deficiencies in knowledge and familial risk communication among colorectal adenoma patients. J Clin Gastroenterol. 2005;39(4):298–302. doi: 10.1097/01.mcg.0000155129.31208.0d. [DOI] [PubMed] [Google Scholar]
  89. Segal J, Esplen MJ, Toner B, Baedorf S, Narod S, Butler K. An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers. Am J Med Genet A. 2004;125A(3):267–272. doi: 10.1002/ajmg.a.20485. [DOI] [PubMed] [Google Scholar]
  90. Shakespeare J. Psychosocial and educational aspects of specific genetic disease: communication in HD families—abstracts of papers and posters presented at the third European meeting on psychosocial aspects of genetics. J Genet Couns. 1993;2(1):53. [Google Scholar]
  91. Sheeran P. Intention-behaviour relations: a conceptual and empirical review. Eur Rev Soc Psychol. 2002;12(1):1–36. doi: 10.1080/14792772143000003. [DOI] [Google Scholar]
  92. Simms AM, Li LC, Reid WD. Development of a theory-based intervention to increase prescription of inspiratory muscle training by health professionals in the management of people with chronic obstructive pulmonary disease. Physiother Can. 2012;63(3):315–323. doi: 10.3138/ptc.2010-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Skirton H. Telling the children. In: Clarke AJ, editor. The genetic testing of children. Oxford: BIOS Scientific Publishers; 1998. pp. 103–111. [Google Scholar]
  94. Smith KR, Zick CD, Mayer RN, Botkin JR. Voluntary disclosure of BRCA1 mutation test results. Genet Test. 2002;6(2):89–92. doi: 10.1089/10906570260199339. [DOI] [PubMed] [Google Scholar]
  95. Sorenson JR, Jennings-Grant T, Newman J. Communication about carrier testing within hemophilia A families. Am J Med Genet C Semin Med Genet. 2003;119C(1):3–10. doi: 10.1002/ajmg.c.10001. [DOI] [PubMed] [Google Scholar]
  96. Suslak L, Price DM, Desposito F. Transmitting balanced translocation carrier information within families: a follow-up study. Am J Med Genet. 1985;20(2):227–232. doi: 10.1002/ajmg.1320200204. [DOI] [PubMed] [Google Scholar]
  97. Suthers GK, Armstrong J, McCormack J, Trott D. Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet. 2006;43(8):665–670. doi: 10.1136/jmg.2005.039172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Taylor S. Gender differences in attitudes among those at risk for Huntington's disease. Genet Test. 2005;9(2):152–157. doi: 10.1089/gte.2005.9.152. [DOI] [PubMed] [Google Scholar]
  99. Trinh L, Plotnikoff RC, Rhodes RE, North S, Courneya KS. Correlates of physical activity in population-based sample of kidney cancer survivors: an application of the theory of planned behavior. Int J Behav Nutr Phys Act. 2012;9(1):96. doi: 10.1186/1479-5868-9-96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. van den Nieuwenhoff HW, Mesters I, Nellissen JJ, Stalenhoef AF, de Vries NK. The importance of written information packages in support of case-finding within families at risk for inherited high cholesterol. J Genet Counsel. 2006;15(1):29–40. doi: 10.1007/s10897-005-9001-8. [DOI] [PubMed] [Google Scholar]
  101. van den Nieuwenhoff HW, Mesters I, Gielen C, de Vries NK. Family communication regarding inherited high cholesterol: why and how do patients disclose genetic risk? Soc Sci Med. 2007;65(5):1025–1037. doi: 10.1016/j.socscimed.2007.04.008. [DOI] [PubMed] [Google Scholar]
  102. van der Roest W, Pennings JM, Bakker M, van den Berg MP, van Tintelen JP. Family letters are an effective way to inform relatives about inherited cardiac disease. Am J Med Genet A. 2009;149A(3):357–363. doi: 10.1002/ajmg.a.32672. [DOI] [PubMed] [Google Scholar]
  103. van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Bröcker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, Van Gool AR, Klijn JGM, Riedijk SR, van Dooren S, Tibben A. A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships. Psychooncology. 2007;16(4):320–328. doi: 10.1002/pon.1062. [DOI] [PubMed] [Google Scholar]
  104. Varekamp I, Suurmeijer T, Brocker-Vriends A, Rosendall FR. Hemophilia and the use of genetic counseling and carrier testing within family networks. Birth Defects Orig Artic Ser. 1992;28(1):139–148. [PubMed] [Google Scholar]
  105. Wagner Costalas J, Itzen M, Malick J, Babb JS, Bove B, Godwin AK, Daly MB. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience. Am J Med Genet C Semin Med Genet. 2003;119C(1):11–18. doi: 10.1002/ajmg.c.10003. [DOI] [PubMed] [Google Scholar]
  106. Wilson B, Etchegary H. Family communication of genomic information. In: Teryack K, editor. Handbook of genomics and the family: psychosocial context for children and adolescents. New York: Springer; 2010. pp. 163–189. [Google Scholar]
  107. Wilson BJ, Forrest K, van Teijlingen ER, McKee L, Haites N, Matthews E, Simpson SA. Family communication about genetic risk: the little that is known. Community Genet. 2004;7(1):15–24. doi: 10.1159/000080300. [DOI] [PubMed] [Google Scholar]
  108. Wiseman M, Dancyger C, Michie S. Communicating genetic risk information within families: a review. Fam Cancer. 2010;9(4):691–703. doi: 10.1007/s10689-010-9380-3. [DOI] [PubMed] [Google Scholar]
  109. Wolff G, Back E, Arleth S, Rapp-Körner U (1989) Genetic counseling in families with inherited balanced translocations: experience with 36 families. Clin Genet 35:404–416 [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ESM 1 (195.9KB, pdf)

(PDF 195 kb)

ESM 2 (509.7KB, pdf)

(PDF 509 kb)


Articles from Journal of Community Genetics are provided here courtesy of Springer

RESOURCES